Trial Profile
Pivotal phase III trial of ultra-rapid acting insulins in patients with type 2 diabetes mellitus.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 30 Sep 2011
Price :
$35
*
At a glance
- Drugs Insulin (Primary) ; Insulin lispro (Primary)
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- 26 Sep 2011 Status changed from planning to discontinued.
- 15 Mar 2011 New trial record